Found: 6

Select item for more details and to access through your institution.

  • Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.

    Published in:
    Cancer Research & Treatment, 2021, v. 53, n. 2, p. 457, doi. 10.4143/crt.2020.585
    By:
    • Boonsri, Boonyakorn;
    • Yacqub-Usman, Kiren;
    • Thintharua, Pakpoom;
    • Kyaw Zwar Myint;
    • Sae-Lao, Thannicha;
    • Collier, Pam;
    • Suriyonplengsaeng, Chinnawut;
    • Larbcharoensub, Noppadol;
    • Balasubramanian, Brinda;
    • Venkatraman, Simran;
    • Egbuniwe, Isioma U.;
    • Gomez, Dhanwant;
    • Mukherjee, Abhik;
    • Kumkate, Supeecha;
    • Janvilisri, Tavan;
    • Zaitoun, Abed M.;
    • Kuakpaetoon, Thiti;
    • Tohtong, Rutaiwan;
    • Grabowska, Anna M.;
    • Bates, David O.
    Publication type:
    Article

  • Untitled.

    Published in:
    Molecules, 2022, v. 27, n. 14, p. N.PAG, doi. 10.3390/molecules27144664
    By:
    • Balasubramanian, Brinda;
    • Venkatraman, Simran;
    • Myint, Kyaw Zwar;
    • Krobthong, Sucheewin;
    • Wongtrakoongate, Patompon;
    • Sripa, Jittiyawadee;
    • Rattanasinganchan, Panthip;
    • Metheenukul, Pornphimon;
    • Tohtong, Rutaiwan
    Publication type:
    Article

  • Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway.

    Published in:
    Oncology Letters, 2018, v. 15, n. 3, p. 3031, doi. 10.3892/ol.2017.7706
    By:
    • Myint, Kyaw Zwar;
    • Kongpracha, Pornparn;
    • Rattanasinganchan, Panthip;
    • Leelawat, Kawin;
    • Moolthiya, PENpak;
    • Chaiyabutr, Kittipong;
    • Tohtong, Rutaiwan
    Publication type:
    Article

  • Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 9, p. 2528, doi. 10.3390/cancers15092528
    By:
    • Balasubramanian, Brinda;
    • Yacqub-Usman, Kiren;
    • Venkatraman, Simran;
    • Myint, Kyaw Zwar;
    • Juengsamarn, Jitlada;
    • Sarkhampee, Poowanai;
    • Lertsawatvicha, Nithi;
    • Sripa, Jittiyawadee;
    • Kuakpaetoon, Thiti;
    • Suriyonplengsaeng, Chinnawut;
    • Wongprasert, Kanokpan;
    • Grabowska, Anna M.;
    • Bates, David O.;
    • Janvilisri, Tavan;
    • Tohtong, Rutaiwan
    Publication type:
    Article

  • Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 197, doi. 10.3390/ph17020197
    By:
    • Myint, Kyaw Zwar;
    • Balasubramanian, Brinda;
    • Venkatraman, Simran;
    • Phimsen, Suchada;
    • Sripramote, Supisara;
    • Jantra, Jeranan;
    • Choeiphuk, Chaiwat;
    • Mingphruedhi, Somkit;
    • Muangkaew, Paramin;
    • Rungsakulkij, Narongsak;
    • Tangtawee, Pongsatorn;
    • Suragul, Wikran;
    • Farquharson, Watoo Vassanasiri;
    • Wongprasert, Kanokpan;
    • Chutipongtanate, Somchai;
    • Sanvarinda, Pimtip;
    • Ponpuak, Marisa;
    • Poungvarin, Naravat;
    • Janvilisri, Tavan;
    • Suthiphongchai, Tuangporn
    Publication type:
    Article

  • Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma.

    Published in:
    Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 51, doi. 10.3390/ph14010051
    By:
    • Balasubramanian, Brinda;
    • Venkatraman, Simran;
    • Myint, Kyaw Zwar;
    • Janvilisri, Tavan;
    • Wongprasert, Kanokpan;
    • Kumkate, Supeecha;
    • Bates, David O.;
    • Tohtong, Rutaiwan
    Publication type:
    Article